Abstract

Published reports of functional abnormalities in schizophrenia remain divergent due to lack of staging point-of-view and whole-brain analysis. To identify key functional-connectivity differences of first-episode (FE) and chronic patients from controls using resting-state functional MRI, and determine changes that are specifically associated with disease onset, a clinical staging model is adopted. We analyze functional-connectivity differences in prodromal, FE (mostly drug naïve), and chronic patients from their matched controls from 6 independent datasets involving a total of 789 participants (343 patients). Brain-wide functional-connectivity analysis was performed in different datasets and the results from the datasets of the same stage were then integrated by meta-analysis, with Bonferroni correction for multiple comparisons. Prodromal patients differed from controls in their pattern of functional-connectivity involving the inferior frontal gyri (Broca’s area). In FE patients, 90% of the functional-connectivity changes involved the frontal lobes, mostly the inferior frontal gyrus including Broca’s area, and these changes were correlated with delusions/blunted affect. For chronic patients, functional-connectivity differences extended to wider areas of the brain, including reduced thalamo-frontal connectivity, and increased thalamo-temporal and thalamo-sensorimoter connectivity that were correlated with the positive, negative, and general symptoms, respectively. Thalamic changes became prominent at the chronic stage. These results provide evidence for distinct patterns of functional-dysconnectivity across FE and chronic stages of schizophrenia. Importantly, abnormalities in the frontal language networks appear early, at the time of disease onset. The identification of stage-specific pathological processes may help to understand the disease course of schizophrenia and identify neurobiological markers crucial for early diagnosis.

Introduction

The pathophysiology of schizophrenia involves distributed functional dysconnectivity involving a number of brain regions,1,2 including the frontal lobe,3–10 and its language-related areas in the inferior frontal gyrus,11,12 sensory-motor areas,13 the temporal lobe,14 limbic structures,15,16 and thalamus.17–24 Despite numerous leads, the reported findings are somewhat inconsistent and the core regions associated with the pathogenesis of schizophrenia still remain controversial.

One important factor may be heterogeneity in patients regarding the stage of illness and medication.25 Recently, the clinical staging model provides an approach to this problem26–28 by offering a lifespan perspective of psychosis, ranging from the prodromal (ultra high-risk) stage through the first-episode (FE) stage to the chronic stage of illness. It avoids an assumption of homogeneity and a grouping together of patients with different levels of illness severity and chronicity, all of which can influence the observed neurobiological landscape of psychiatric disorders. In a review of investigations that did compare FE and chronic stages of schizophrenia, it was concluded that schizophrenia is associated with dysconnectivity that is particularly evident in the connections involving the frontal lobe, and that this applies across all stages of the disorder.2 There are additional studies that have focused on the early changes in schizophrenia, including.6,12,15,29–32

Another important factor in the heterogeneity of the findings may be that many studies have focused on functional connectivity between regions specified a priori, rather than adopting a whole-brain analysis. Consequently the reported findings are influenced by choice of the regions of interest, and may not cover the most significantly different areas that may reflect the core pathological changes in schizophrenia. A third important factor is that many studies have utilized relatively few patients and controls, often in the region of 10–40 patients and controls,2 and this may somewhat limit the reproducibility of the findings.

Given this background, the investigation described here first aims to provide evidence on functional connectivity differences in a large group of drug-naïve FE patients with schizophrenia using brain-wide resting-state functional connectivity analyses. This is especially important for understanding the changes at the onset of the disorder. We further aim to identify differences in functional connectivity from controls of another large group of chronic schizophrenic patients (who are receiving medication), for patients at this stage are the usual participants in functional connectivity studies, and it is important to know how the connectivity differences in FE unmedicated patients differ from what is usually studied. In addition, we measured functional connectivity differences from controls in a small prodromal (ultra high-risk) group, some of whom are likely to develop schizophrenia, to investigate whether some of the differences in the FE patients were becoming evident in the prodromal group, as this would further implicate these differences in the onset stage of schizophrenia. Here the FE patients were defined as having illness duration less than a year, while chronic patients were defined as having illness duration longer than a year.

To achieve these goals, we adopted a whole-brain analysis using resting-state datasets from multiple neuroimaging centers to provide large numbers of patients and controls, and integrated the results by a meta-analytic approach that we developed,33,34 for both FE and chronic schizophrenia. Our results for FE patients (largely antipsychotic-naïve) are crucial to identify the core regions relevant to pathogenesis before the patients are exposed to antipsychotic treatment.23 Combining these results with chronic schizophrenia patients, we evaluate whether there are more widespread neurobiological differences, and whether the profile of functional dysconnectivity is different, across stages, to provide evidence on the pathophysiology of schizophrenia.

Methods

Participants

There were altogether 1050 subjects enrolled (479 patients) in our study, which were from 6 different datasets that have all been reported. As we combine multi-center data with possibly large variation, it is important to set up a protocol to ensure data quality. The exclusion criteria were: (1) Subjects with poor structural scans, or without complete demographic information and Positive and Negative Syndrome Scale (PANSS) scores, or age <16; (2) Head movement: subjects with >10% displaced frames in a scrubbing procedure or maximal motion between volumes in each direction >3mm, and rotation about each axis >3 were excluded; (3) Patients and controls were screened in each dataset so that age, gender, education, head movements, and the total root mean square displacements did not show significant differences.

After data quality control, 789 subjects were left, including 343 patients (17 high-risk subjects, 197 FE patients, 146 chronic schizophrenia). These subjects are from Dataset 1# (Shanghai Mental Health Centre, prodromal, described in supplementary text S1); Dataset 2# (Huaxi hospital,19 FE); Dataset 3# (Central South University,35 FE); Dataset 4# (The Center for Biomedical Research Excellence-COBRE,36 chronic); Dataset 5# (National Taiwan University Hospital,37 chronic); Dataset 6# (First Affiliated Hospital of China Medical University,38 FE and chronic). Detailed demographics of the patients are provided in table 1. The FE schizophrenia patients were defined as having illness duration ≤ 12 months (with a mean of 0.27 mo in our dataset), while the chronic patients were defined as having illness duration > 12 months (with a mean of 8.2 y, ie, 98.4 mo in our dataset). A small prodromal group consisted of participants who are putatively prodromal for psychosis due to being at clinical high risk as defined by the SIPS/SOPS.

Table 1.

Demographic and Clinical Characteristics of Patients in Datasets 1# to 6#

SitesNumberAge (y)PSex (Male/ Female)PP ScaleN ScaleG ScaleDuration of Illness (y)Medication
1# Shanghai Mental Health CenterControl 23 (23)27.8±8.7.5214/ 9.99
Patient 17 (18)26.1±8.110/ 7ProdromalDrug-naïve
2# HuaxiControl 150 (180)25.8±8.7.1980/ 70.36
Patient 113 (178)24.4±7.853/ 6025.4±5.619.1±7.047.8±9.00.01–1 (0.24±0.27) FEDrug-naïve
3# XiangyaControl 57 (60)26.3±5.5.2432/ 25.51
Patient 39 (83)24.6±6.626/ 1419.8±6.321.6±7.739.2±11.80.08–1 (0.3±0.3) FE25 Medicated; 14 Drug-naïve
4# COBREControl 53 (74)34.8±11.3.4042/ 11.13
Patient 67 (71)36.8±13.746/ 2114.9±4.614.7±5.229.7±8.22–24 (8.9±6.9) ChronicMedicated
5# TaiwanControl 62 (62)31.6±8.1.0825/ 37.21
Patient 56 (69)33.3±9.330/ 2610±512.7±7.523.8±11.81–31 (8.8±6.2)Medicated
6# First Affiliated Hospital of China Medical Univ.Control 63a (154)27.1±10.6.2031/ 32.06Matched with FE patients
Patient 45 (53)24.7±9.319/ 260.30±0.26 (FE)22 Drug-naïve
Control 84a (154)32.8±13.4.3340/ 44.91Matched with chronic patients
Patient 23 (25)30±9.210/ 134.4±2.8 Chronic4 Drug-naïve
SitesNumberAge (y)PSex (Male/ Female)PP ScaleN ScaleG ScaleDuration of Illness (y)Medication
1# Shanghai Mental Health CenterControl 23 (23)27.8±8.7.5214/ 9.99
Patient 17 (18)26.1±8.110/ 7ProdromalDrug-naïve
2# HuaxiControl 150 (180)25.8±8.7.1980/ 70.36
Patient 113 (178)24.4±7.853/ 6025.4±5.619.1±7.047.8±9.00.01–1 (0.24±0.27) FEDrug-naïve
3# XiangyaControl 57 (60)26.3±5.5.2432/ 25.51
Patient 39 (83)24.6±6.626/ 1419.8±6.321.6±7.739.2±11.80.08–1 (0.3±0.3) FE25 Medicated; 14 Drug-naïve
4# COBREControl 53 (74)34.8±11.3.4042/ 11.13
Patient 67 (71)36.8±13.746/ 2114.9±4.614.7±5.229.7±8.22–24 (8.9±6.9) ChronicMedicated
5# TaiwanControl 62 (62)31.6±8.1.0825/ 37.21
Patient 56 (69)33.3±9.330/ 2610±512.7±7.523.8±11.81–31 (8.8±6.2)Medicated
6# First Affiliated Hospital of China Medical Univ.Control 63a (154)27.1±10.6.2031/ 32.06Matched with FE patients
Patient 45 (53)24.7±9.319/ 260.30±0.26 (FE)22 Drug-naïve
Control 84a (154)32.8±13.4.3340/ 44.91Matched with chronic patients
Patient 23 (25)30±9.210/ 134.4±2.8 Chronic4 Drug-naïve

Note: FE, first-episode. The number in brackets of the column “Number” indicates the number of subjects before quality control. There are 40 subjects in prodromal dataset (17 patients), 467 subjects in FE (197 patients) dataset, and 345 subjects in chronic stage dataset (146 patients). Note that dataset 6# does not have Positive and Negative Syndrome Scale (PANSS) scores but BPRS scores, therefore is involved only in the whole-brain analysis but not in the correlation analysis with symptom scores. Patients are matched with corresponding controls in each dataset for age, sex, handedness, and head movements.

aThe 84 controls (matched with chronic patients) included all 63 controls that matched with the FE patients in dataset 6#.

Table 1.

Demographic and Clinical Characteristics of Patients in Datasets 1# to 6#

SitesNumberAge (y)PSex (Male/ Female)PP ScaleN ScaleG ScaleDuration of Illness (y)Medication
1# Shanghai Mental Health CenterControl 23 (23)27.8±8.7.5214/ 9.99
Patient 17 (18)26.1±8.110/ 7ProdromalDrug-naïve
2# HuaxiControl 150 (180)25.8±8.7.1980/ 70.36
Patient 113 (178)24.4±7.853/ 6025.4±5.619.1±7.047.8±9.00.01–1 (0.24±0.27) FEDrug-naïve
3# XiangyaControl 57 (60)26.3±5.5.2432/ 25.51
Patient 39 (83)24.6±6.626/ 1419.8±6.321.6±7.739.2±11.80.08–1 (0.3±0.3) FE25 Medicated; 14 Drug-naïve
4# COBREControl 53 (74)34.8±11.3.4042/ 11.13
Patient 67 (71)36.8±13.746/ 2114.9±4.614.7±5.229.7±8.22–24 (8.9±6.9) ChronicMedicated
5# TaiwanControl 62 (62)31.6±8.1.0825/ 37.21
Patient 56 (69)33.3±9.330/ 2610±512.7±7.523.8±11.81–31 (8.8±6.2)Medicated
6# First Affiliated Hospital of China Medical Univ.Control 63a (154)27.1±10.6.2031/ 32.06Matched with FE patients
Patient 45 (53)24.7±9.319/ 260.30±0.26 (FE)22 Drug-naïve
Control 84a (154)32.8±13.4.3340/ 44.91Matched with chronic patients
Patient 23 (25)30±9.210/ 134.4±2.8 Chronic4 Drug-naïve
SitesNumberAge (y)PSex (Male/ Female)PP ScaleN ScaleG ScaleDuration of Illness (y)Medication
1# Shanghai Mental Health CenterControl 23 (23)27.8±8.7.5214/ 9.99
Patient 17 (18)26.1±8.110/ 7ProdromalDrug-naïve
2# HuaxiControl 150 (180)25.8±8.7.1980/ 70.36
Patient 113 (178)24.4±7.853/ 6025.4±5.619.1±7.047.8±9.00.01–1 (0.24±0.27) FEDrug-naïve
3# XiangyaControl 57 (60)26.3±5.5.2432/ 25.51
Patient 39 (83)24.6±6.626/ 1419.8±6.321.6±7.739.2±11.80.08–1 (0.3±0.3) FE25 Medicated; 14 Drug-naïve
4# COBREControl 53 (74)34.8±11.3.4042/ 11.13
Patient 67 (71)36.8±13.746/ 2114.9±4.614.7±5.229.7±8.22–24 (8.9±6.9) ChronicMedicated
5# TaiwanControl 62 (62)31.6±8.1.0825/ 37.21
Patient 56 (69)33.3±9.330/ 2610±512.7±7.523.8±11.81–31 (8.8±6.2)Medicated
6# First Affiliated Hospital of China Medical Univ.Control 63a (154)27.1±10.6.2031/ 32.06Matched with FE patients
Patient 45 (53)24.7±9.319/ 260.30±0.26 (FE)22 Drug-naïve
Control 84a (154)32.8±13.4.3340/ 44.91Matched with chronic patients
Patient 23 (25)30±9.210/ 134.4±2.8 Chronic4 Drug-naïve

Note: FE, first-episode. The number in brackets of the column “Number” indicates the number of subjects before quality control. There are 40 subjects in prodromal dataset (17 patients), 467 subjects in FE (197 patients) dataset, and 345 subjects in chronic stage dataset (146 patients). Note that dataset 6# does not have Positive and Negative Syndrome Scale (PANSS) scores but BPRS scores, therefore is involved only in the whole-brain analysis but not in the correlation analysis with symptom scores. Patients are matched with corresponding controls in each dataset for age, sex, handedness, and head movements.

aThe 84 controls (matched with chronic patients) included all 63 controls that matched with the FE patients in dataset 6#.

All patients were diagnosed by the DSM-IV diagnostic criteria39 by qualified psychiatrists utilizing all available clinical information including a diagnostic interview, clinical case notes and clinician’s observation. Symptom severity was measured using the PANSS40 assessment (for high-risk subjects for psychosis, ie, Dataset 1# see supplementary text S1). The FE patients were all confirmed as schizophrenic by at least a 6-month follow-up. All healthy controls were assessed by clinicians in accordance with DSM-IV criteria as being free of schizophrenia and other Axis I disorders, and none had neurological diseases, head trauma or substance dependence. Written informed consent was obtained from all individual participants, and ethical guidelines were approved by the Institutional Review Boards (IRB) of the respective hospitals (Taiwan, mainland China and United States). All subjects underwent resting-state functional MRI (fMRI) scanning for 5–7 minutes, and were asked to relax and think of nothing in particular and not to fall asleep. The imaging acquisition protocols for 6 datasets are provided in the supplementary methods S2.

Image Preprocessing

All fMRI data were preprocessed using SPM8: the data were realigned and normalized to a standard template (Montreal Neurological Institute) and resampled to 3×3 × 3mm voxels. All fMRI time-series underwent band-pass temporal filtering (0.01–0.08 Hz), nuisance signal removal from ventricles, deep white matter, global mean signal removal, and 6-parameter rigid-body motion correction. 90 regional time series were extracted by averaging voxel time series within each anatomically defined region (using the Automated-Anatomical-Labeling template41). We carefully performed the following procedures to achieve motion correction: (1) Three-dimensional motion correction and (2) Data scrubbing as described by Power et al.42 The frames whose frame-wise displacement >0.5mm were all deleted together with 1 preceding and 2 succeeding frames (see supplementary methods S1 for data scrubbing details). A discussion of global signal removal can be found in the supplementary methods S1.

Statistical Analysis

Clinical Staging Model.

To identify stage-specific functional-connectivity changes, we first took a staging model perspective and performed whole brain functional connectivity analysis for each dataset by comparing patients with matched controls. We then used meta-analysis43 to integrate the results of patients of the same stage (FE: involving Datasets 2#, 3# and 6#; Chronic: involving Datasets 4#, 5#, and 6#).

Whole-Brain Functional-Connectivity Analysis in Each Dataset.

The Pearson cross-correlations between all pairs of regional BOLD signals were calculated, and the whole-brain functional connectivity network (90×90 automatic anatomical labelling [AAL] region-based network with altogether 4005 edges) was constructed. A 2-sample, 2-tailed t test was performed to obtain the P value for every functional connectivity link in each dataset, with age, sex, root-mean-square displacements of head movement, and dosage (if the dataset contains both medicated and drug-naïve patients) being regressed out. If the dataset contained patients at different stages, we performed the analysis separately for each stage.

Meta-analysis to Integrate Results for the Same Stage From Different Imaging Centers.

We used a Liptak-Stouffer z-score method43 which is well-validated in integrating results from individual datasets (eg, MRI31) as follows. For a specific stage of schizophrenia, the p-value of each functional connectivity in the relevant dataset i was converted to the corresponding z score: zi = Φ−1 (1−pi), where Φ is the standard normal cumulative distribution function. Then a combined z-score for a functional connectivity was obtained using the Liptak-Stouffer formula:

Z=i=1kwizii=1kwi2

where wi is the inverse of the variance of zi. Z follows a standard normal distribution under the null hypothesis and is transformed into its corresponding P-value, with Bonferroni correction used to correct for multiple comparisons.

Finally, we perform Pearson correlation analysis between each identified functional connectivity (through meta-analysis) with the PANSS scores of schizophrenia, with Bonferroni correction used to correct for multiple comparisons.

Results

Stage-Specific Functional-Connectivity Alterations

Prodromal Stage (Ultra High-Risk Subjects).

In patients, functional connectivity differed from controls in the frontal regions, in particular between the orbital part of the inferior frontal gyrus and the angular gyrus; the inferior frontal gyrus triangular part and the precuneus; and the medial part of the superior frontal gyrus and the inferior temporal gyrus, as shown in supplementary table S1. These inferior frontal gyrus regions include parts of Broca’s area and are implicated in language.32

First-Episode.

The meta-analytic approach involving FE patients from multiple centers (2#, 3# and 6#) revealed 82 functional connections that significantly differed from controls (Bonferroni correction). 77 (94%) of these involved the frontal lobe (figures 1a and 1b and supplementary table S2, the most significant link has P = 1.2×10–12), with 35 (43%) involving the opercular (Brodmann area BA 44) and triangular (BA 45) parts of the inferior frontal gyrus (Broca’s area) and 18 (22%) involving the orbital part of the inferior frontal gyrus which includes part of Broca’s area32 (and corresponds in part with BA 47). Striking changes involved Broca’s area (IFGoperc and IFGtriang) which had increased functional connectivity with the superior frontal gyrus, medial frontal gyrus, anterior cingulate cortex, precuneus, middle temporal gyrus, and temporal pole; and the orbital part of the inferior frontal gyrus (Frontal_Inf_Orb) which had increased connectivity with the superior frontal gyrus, the precuneus and the posterior cingulate cortex; and decreased connectivity with the precentral and postcentral cortex (motor and somatosensory) cortex, inferior parietal cortex and Rolandic operculum (figure 1a and supplementary table S2). The other connectivity differences included for the gyrus rectus (part of the ventral medial prefrontal cortex) increased connectivity with the angular gyrus and decreased connectivity with the fusiform gyrus and temporal pole; and for the middle frontal gyrus (Frontal_Mid) and an anterolateral part of the orbital cortex (Frontal_Mid_Orb) that may include part of Brodmann area 10 some increased functional connectivity links (figure 1b and supplementary table S2).

Fig. 1.

Significantly altered functional connectivity for first-episode schizophrenia by meta-analysis involving Datasets 2#, 3#, and 6#. The color of the 3 circles (from outside to inside) denotes: the 90 different automatic anatomical labelling (AAL) regions (First circle); the number of increased links (Second circle, deep red means a region has more increased links); the number of decreased links (Third circle, deep blue means a region has more decreased links). The thickness of the links is proportional to –log10 (P value). The right of the brain is on the right of each circular diagram. (a) illustrates altered links of the inferior frontal lobe (51 links, including the opercular, triangular and orbital part), and (b) is for the remaining links. Red links indicate that patients have a higher mean functional connectivity than controls (ie, mean (FC_patient) − mean(FC_control) > 0), and blue links indicate the opposite.

Chronic Stage.

For the chronic stage, the meta-analytic approach involving chronic stage datasets from multiple centers (4#, 5# and 6#) showed that functional connectivity differences from controls became much more widespread (with 162 altered links, Bonferroni correction), most prominently in the thalamus bilaterally (58 links, the most significant link has P = 1.2×10–19), and the cingulate cortex (49 links, mainly to occipital and subcortical regions, most significant link has P = 7.6×10–12), see figures 2ac, figure 3 and supplementary table S3a. The increased functional connectivity between the thalamus and the precentral and postcentral gyrus, middle temporal gyrus and nearby temporal cortex areas, and the fusiform and lingual gyri was striking (figure 2a and supplementary table S3). In contrast, there was decreased functional connectivity between the thalamus and some frontal cortical areas (figure 2a and supplementary table S3a). The cingulate cortex had increased functional connectivity with occipital areas, and decreased functional connectivity with subcortical structures including the thalamus and basal ganglia (figure 2b and supplementary table S3b). Finally, the basal ganglia had increased functional connectivity with the middle temporal gyrus, and decreased functional connectivity with the supramarginal and inferior parietal gyri (figure 2c and supplementary table S3c).

Fig. 2.

Significantly altered functional connectivity for chronic stage schizophrenia by meta-analysis involving Datasets 4#, 5#, and 6#. (a) illustrates altered links involving the thalamus (58 links), and (b) is for links involving the cingulate cortex (49 links). (c) is for the remaining significantly different links.

Fig. 3.

The number of significantly different functional connectivity links of each brain region for (a) first-episode (FE) and (b) chronic stage schizophrenia patients. (a) and (b) were obtained by counting the number of different links in supplementary tables S2 and S3 for each pair of symmetric brain regions (ie, we added the number of links of the left and right corresponding regions). For FE patients, 46 regions (out of 90 automatic anatomical labelling [AAL] regions) showed differences from controls, and for chronic stage patients, 67 regions demonstrated differences from controls. Regions marked green are those demonstrating common changes in both FE and chronic stages (these regions have more than 2.5% altered-links in both stages), including the middle frontal gyrus, posterior cingulate cortex, the fusiform gyrus, and the temporal pole. Regions marked pink are those demonstrating stage-specific changes. Inferior and medial frontal gyrus changes were found in FE schizophrenia, and cingulate, subcortical (especially the thalamus), and occipital changes were found in the chronic stage.

Correlations With the Symptom Scores and Illness Duration

For the FE patients (supplementary table S4a), functional links involving Broca’s area (Frontal_Inf_operc and Frontal_Inf_triang) were correlated with the PANSS positive and negative sum scores. Functional connectivity of Frontal_Inf_Orb (which is part of or related to Broca’s area and the lateral orbitofrontal cortex) was correlated with Lack of judgment and insight. Functional connectivity links of Frontal_Mid_Orb (an anterolateral part of the orbital cortex that includes part of area 10) were correlated with Difficulty in abstract thinking and Uncooperativeness. Functional connectivity links of Frontal_Sup_Medial (medial prefrontal cortex area 10) were correlated with the negative and positive sum scores, with Difficulty in abstract thinking, Uncooperativeness, and Lack of judgment and insight (supplementary table S4a). Functional connectivity links of the middle frontal gyrus (Frontal_Mid) were correlated with the positive sum score, and with Uncooperativeness (and for the superior frontal gyrus with Lack of Judgment and Insight).

For the chronic patients (supplementary table S4b), the positive symptoms (delusions, hallucinations and suspiciousness) were correlated with the functional connectivities of the thalamus with the pre/postcentral gyrus, superior medial and middle frontal gyrus. The negative symptoms (blunted affect and social withdrawal) were positively correlated with functional connectivity of the posterior cingulate with the lingual and fusiform gyrus, and superior occipital gyrus. Posterior cingulate-fusiform connectivity was positively correlated with the general subscores of motor retardation, disturbance of volition, and preoccupation (supplementary table S4b). The connectivity associated with precuneus and subcortical structures correlated significantly with illness duration, see supplementary table S5.

Stage-Specific Functional Alteration Across Stages

For the FE patients (197 patients and 270 controls), 46 brain regions (figure 3a) showed functional connectivity changes (involving 82 links), compared with 67 regions (figure 3b, involving 162 links) for the chronic stage (146 patients and 199 controls). These more widespread functional connectivity changes in the chronic stage imply an apparent spreading of functional alterations to more regions after disease onset. We also found stage-specific changes: alterations in the FE patients primarily involved the frontal lobe, including Broca’s area (IFGoperc and IFGtriang); while for the chronic stage, posterior cingulate, subcortical areas (especially the thalamus), the lingual gyrus, cuneus and occipital areas showed the most prominent changes (pink regions in figure 3). The data shown in figure 3 use Bonferroni correction. To examine to what extent the frontal regions with altered functional connectivity were still evident in chronic schizophrenia, we show similar data to those in figure 3, but now with FDR statistical correction in supplementary figure S1. This shows that some frontal functional connectivity differences are still evident in chronic patients, but that other areas are now more involved. The differences in these frontal vs other patterns of involvement in FE and chronic patients were still statistically significant with the FDR-corrected data (χ2 = 553.21, df = 44, P < 10–50).

Discussion

We report a functional neuroimaging analysis examining the functional dysconnectivity at different stages of schizophrenia using 6 independent datasets. To our knowledge, this is the first imaging study to directly examine the effect of functional connectivity changes at FE and chronic stages in schizophrenia with large multi-center datasets, with large numbers of patients, and with the almost unique data from drug-naive FE patients with schizophrenia. The FE schizophrenia patients demonstrated most prominently localized changes in the frontal lobes, especially Broca’s area and the orbital part of the inferior frontal gyrus, indicating that the frontal differences from controls have an early-onset nature. For the chronic stage of schizophrenia, much wider functional-connectivity changes were found, mostly prominently involving the thalamus.

Both thalamic and frontal abnormalities have been widely reported in schizophrenia. However, the results for the regions responsible for the core pathogenesis remain inconsistent, partly due to a number of factors such as the lack of a staging point of view, small sample sizes, and confounding factors such as the effects of medication. The thalamus is connected to all cortical areas and conveys information to the neocortex, including information from the basal ganglia. Though a number of other studies have identified thalamic connectivity changes in the chronic stage of schizophrenia,17,19,22–24 such studies provide little information about early illness pathophysiology. In contrast, studies of FE schizophrenia have the advantage to specify brain changes at illness onset, thus providing crucial information about the pathogenesis of schizophrenia. Our functional-connectivity analysis of 197 FE schizophrenia patients (76% being drug-naïve, and the results for the drug-naïve subset shown in supplementary table S7) shows localized changes in the frontal lobes, suggesting these to be core regions for schizophrenia pathogenesis. Further, we found that subjects at high risk of psychosis (the prodromal stage) also had functional connectivity changes primarily associated with the frontal lobes (especially the inferior frontal gyrus which includes Broca’s area). These results in combination suggest a key neuropathological role of the frontal lobe in the onset of schizophrenia. The data presented in this investigation provide an important contribution to this evidence, for we analyzed data from hundreds of FE patients who were largely drug-naïve (ie, who had never received treatment), and therefore provide key information about the early changes in the brain in schizophrenia.

Functional abnormalities of the frontal lobe have been one of the most consistent findings in schizophrenia, although they have not generally been localized to the inferior frontal gyrus.4–10,44,45 Part of the importance of the present investigation is that it shows that frontal functional connectivity changes involving the inferior frontal gyrus are present in FE, antipsychotic-naive patients. A recent review2 of functional connectivity changes in schizophrenia involved typically much smaller sample sizes than those reported here, and reported typically altered functional connectivity in patients sometimes involving the frontal lobe, but without much emphasis on the thalamus, and with no marked stage-specific differences in functional connectivity. In contrast, with the larger sample size and brain-wide approach described here, we found that Broca’s area in the inferior frontal gyrus had increased functional connectivity, which is the most significant changes in FE schizophrenia, and that increased thalamic connectivity including with somatosensory and motor areas in the postcentral and precentral gyrus was prominent in chronic schizophrenia. We further note the smaller prominence of frontal connectivity changes in, eg, the inferior frontal gyrus in the chronic stage, though differences from controls were still evident with FDR correction as shown in supplementary table S6.

The inferior frontal gyrus, which includes Broca’s area, is critically involved in speech production and language processing.46 It is functionally connected with the temporal lobe to form a language network. Our findings of increased functional connectivity of the inferior frontal gyrus including Broca’s area with temporal cortex and cingulate areas, and the correlation of increased functional connectivity with the positive/negative symptoms, implicate language-related frontal areas as key regions related to the onset of schizophrenia. As Broca’s area is important for syntactic functions,47 we suggest that this increased connectivity may be related to the thought disorders in schizophrenia, as syntax is important in multi-step thinking.48 It is interesting to note that the predisposition to schizophrenia may be a component of a Homo sapiens-specific variation associated with the capacity for language.49 Our results are consistent with this hypothesis.

We note that thalamic changes have been reported in FE schizophrenia21,50 and high-risk subjects.51 In our dataset, however, we did not find prominent thalamic functional connectivity differences from controls in FE schizophrenic patients or high-risk subjects. This seeming discrepancy may be due to the different methodology we adopted. In our work we used whole-brain functional-connectivity analysis with strict Bonferroni correction. Therefore only the most significant changes of the whole brain (herein the functional connectivity alterations of the inferior frontal gyrus) are identified. In contrast, the work21,51 used a seed-based approach and focused exclusively on the thalamus, and the changes in other parts of the brain were not systematically evaluated. Consequently our results do not contradict previous works, but revealed brain-wide changes rather than changes associated with pre-defined regions of interest. It is important to note that we do not exclude the possible neuropathological role of the thalamus in FE schizophrenia or the prodromal stage. In fact with FDR correction (q = 0.05) adopted, thalamic changes are also present in FE patients in our data, as shown in supplementary figure S1 and table S6. Our results suggest that thalamic alterations cannot be ruled out in FE schizophrenia, but are less evident than at the chronic stage.

Several strengths and limitations should be noted. A strength is that we used the largest multisite dataset reported with a meta-analytic approach to address inter-site variations. Meta-analysis is more suitable than traditional validation approaches that test if the same observation survives a type-I error, as it considers the effect-size distribution to be more important than if observations survive arbitrarily set thresholds. We note that separate analysis in each dataset (with Bonferroni correction) yields similar results, see table 2. For FE patients, both dataset 2# and 3# demonstrate increased connectivity between the inferior frontal gyrus (orbital part) and superior frontal gyrus. For the chronic stage, both datasets 4# and 5# demonstrate decreased connectivity between the thalamus and middle frontal gyrus, and decreased connectivity between the thalamus and postcentral gyrus. Another strength is the involvement of hundreds of FE patients the great majority of whom were not receiving medication, and the changes in functional connectivity that we found in these patients provide important data for understanding the pathogenesis of schizophrenia.

Table 2.

Overlapped Functional-Connectivity (Using Bonferroni Correction) in Separate Analyses of Each Dataset for FE (#2, #3, and #6) and Chronic Schizophrenia (#4 and #5)

First-Episode
Brain RegionBrain RegionControl (Mean)Patient (Mean)P
Dataset 2#Dataset 3#Dataset 2#Dataset 3#Dataset 2#Dataset 3#
Frontal_Inf_Orb_RFrontal_Sup_L−0.07±0.22−0.19±0.210.08±0.240.03±0.211.3E-062.4 E-06
Dataset 6#Dataset 6#
Fron_Inf_Tri_RFron_Med_Orb_L−0.30±0.19−0.11±0.234.9 E-06
Fron_Inf_Oper_LPrecentral_R0.19±0.20−0.01±0.246.7 E-06
Chronic
Brain regionBrain regionControl (mean)Patient (mean)P
Dataset 4#Dataset 5#Dataset 4#Dataset 5#Dataset 4#Dataset 5#
Thalamus_LFron_Mid_R0.04±0.240.20±0.24−0.21±0.23−0.15±0.282.2E-075.0E-10
Thalamus_RPostcentral_L−0.23±0.28−0.32±0.270.03±0.250.02±0.294.8E-072.4E-08
Thalamus_RFron_Mid_R0.10±0.250.26±0.23−0.14±0.24−0.08±0.296.4E-071.2E-09
Thalamus_RPostcentral_R−0.20±0.29−0.33±0.270.06±0.26−0.001±0.322.2E-061.9E-07
Thalamus_LPostcentral_R−0.21±0.29−0.35±0.260.04±0.26−0.01±0.324.9E-068.3E-08
First-Episode
Brain RegionBrain RegionControl (Mean)Patient (Mean)P
Dataset 2#Dataset 3#Dataset 2#Dataset 3#Dataset 2#Dataset 3#
Frontal_Inf_Orb_RFrontal_Sup_L−0.07±0.22−0.19±0.210.08±0.240.03±0.211.3E-062.4 E-06
Dataset 6#Dataset 6#
Fron_Inf_Tri_RFron_Med_Orb_L−0.30±0.19−0.11±0.234.9 E-06
Fron_Inf_Oper_LPrecentral_R0.19±0.20−0.01±0.246.7 E-06
Chronic
Brain regionBrain regionControl (mean)Patient (mean)P
Dataset 4#Dataset 5#Dataset 4#Dataset 5#Dataset 4#Dataset 5#
Thalamus_LFron_Mid_R0.04±0.240.20±0.24−0.21±0.23−0.15±0.282.2E-075.0E-10
Thalamus_RPostcentral_L−0.23±0.28−0.32±0.270.03±0.250.02±0.294.8E-072.4E-08
Thalamus_RFron_Mid_R0.10±0.250.26±0.23−0.14±0.24−0.08±0.296.4E-071.2E-09
Thalamus_RPostcentral_R−0.20±0.29−0.33±0.270.06±0.26−0.001±0.322.2E-061.9E-07
Thalamus_LPostcentral_R−0.21±0.29−0.35±0.260.04±0.26−0.01±0.324.9E-068.3E-08

Note: For FE patients, both #2 and #3 show significant change in the functional connectivity between the inferior frontal gyrus (orbital) and superior frontal gyrus. #6 also shows changes in the inferior frontal gyrus (triangular and opercular parts). For the chronic stage, both #4 and #5 show significant changes between the thalamus and postcentral gurus; and between the thalamus and the middle frontal gyrus. Age and sex are regressed out in the whole brain functional-connectivity analysis of each dataset. The mean and standard deviation of the functional connectivity (Pearson correlation) for patients and controls are shown.

Table 2.

Overlapped Functional-Connectivity (Using Bonferroni Correction) in Separate Analyses of Each Dataset for FE (#2, #3, and #6) and Chronic Schizophrenia (#4 and #5)

First-Episode
Brain RegionBrain RegionControl (Mean)Patient (Mean)P
Dataset 2#Dataset 3#Dataset 2#Dataset 3#Dataset 2#Dataset 3#
Frontal_Inf_Orb_RFrontal_Sup_L−0.07±0.22−0.19±0.210.08±0.240.03±0.211.3E-062.4 E-06
Dataset 6#Dataset 6#
Fron_Inf_Tri_RFron_Med_Orb_L−0.30±0.19−0.11±0.234.9 E-06
Fron_Inf_Oper_LPrecentral_R0.19±0.20−0.01±0.246.7 E-06
Chronic
Brain regionBrain regionControl (mean)Patient (mean)P
Dataset 4#Dataset 5#Dataset 4#Dataset 5#Dataset 4#Dataset 5#
Thalamus_LFron_Mid_R0.04±0.240.20±0.24−0.21±0.23−0.15±0.282.2E-075.0E-10
Thalamus_RPostcentral_L−0.23±0.28−0.32±0.270.03±0.250.02±0.294.8E-072.4E-08
Thalamus_RFron_Mid_R0.10±0.250.26±0.23−0.14±0.24−0.08±0.296.4E-071.2E-09
Thalamus_RPostcentral_R−0.20±0.29−0.33±0.270.06±0.26−0.001±0.322.2E-061.9E-07
Thalamus_LPostcentral_R−0.21±0.29−0.35±0.260.04±0.26−0.01±0.324.9E-068.3E-08
First-Episode
Brain RegionBrain RegionControl (Mean)Patient (Mean)P
Dataset 2#Dataset 3#Dataset 2#Dataset 3#Dataset 2#Dataset 3#
Frontal_Inf_Orb_RFrontal_Sup_L−0.07±0.22−0.19±0.210.08±0.240.03±0.211.3E-062.4 E-06
Dataset 6#Dataset 6#
Fron_Inf_Tri_RFron_Med_Orb_L−0.30±0.19−0.11±0.234.9 E-06
Fron_Inf_Oper_LPrecentral_R0.19±0.20−0.01±0.246.7 E-06
Chronic
Brain regionBrain regionControl (mean)Patient (mean)P
Dataset 4#Dataset 5#Dataset 4#Dataset 5#Dataset 4#Dataset 5#
Thalamus_LFron_Mid_R0.04±0.240.20±0.24−0.21±0.23−0.15±0.282.2E-075.0E-10
Thalamus_RPostcentral_L−0.23±0.28−0.32±0.270.03±0.250.02±0.294.8E-072.4E-08
Thalamus_RFron_Mid_R0.10±0.250.26±0.23−0.14±0.24−0.08±0.296.4E-071.2E-09
Thalamus_RPostcentral_R−0.20±0.29−0.33±0.270.06±0.26−0.001±0.322.2E-061.9E-07
Thalamus_LPostcentral_R−0.21±0.29−0.35±0.260.04±0.26−0.01±0.324.9E-068.3E-08

Note: For FE patients, both #2 and #3 show significant change in the functional connectivity between the inferior frontal gyrus (orbital) and superior frontal gyrus. #6 also shows changes in the inferior frontal gyrus (triangular and opercular parts). For the chronic stage, both #4 and #5 show significant changes between the thalamus and postcentral gurus; and between the thalamus and the middle frontal gyrus. Age and sex are regressed out in the whole brain functional-connectivity analysis of each dataset. The mean and standard deviation of the functional connectivity (Pearson correlation) for patients and controls are shown.

A limitation is that most of the chronic patients were receiving medication, so it is difficult to be sure about whether the differences between the FE and chronic patients are related to disease progress or the effects of medication on the functional connectivity. Nevertheless, the data presented here are important, for they provide insight into how the functional connectivity of untreated FE patients is different from that of most patients seen clinically, who will be receiving medication. To provide some evidence on the possible role of medication, for FE datasets 3# and 6# (containing both medicated and drug-naive patients), we examined whether medicated and drug-naive patients showed significant differences in functional connectivity, as shown in supplementary table S8a. Only a few links had P < .05 (uncorrected). We furthermore used only drug-naïve FE patients in the meta-analysis shown in supplementary table S7, and found 62 significantly changed connectivities, 50 of which overlap with those obtained by using all FE patients (supplementary table S2). For the chronic dataset 4# (all patients are medicated), we performed a correlation analysis between the significantly different functional connectivities and the medication dosage, as shown in supplementary table S8b. Only 3 links (out of 162) show correlation with the dose of medication (P < .05, uncorrected). Furthermore, though antipsychotic medication may vary across sites, separate analysis of chronic Datasets 4# and 5# revealed the same thalamus-post/precentral dysconnectivity (table 2) that correlated with tension, suggesting that thalamic changes may not depend critically on the type of medication. Another limitation is that we used the AAL atlas to define the different brain areas to be analyzed.41 It would thus be interesting to use functional atlases52 or extend the investigation to voxel-level. Finally, there is no follow up data in Dataset #1 (high-risk subjects) to indicate the transition, and the sample size is not large. We also note that the chronic patients in this study had illness durations that were typically of many years (table 1).

Conclusions

With large multicenter resting-state fMRI datasets and whole-brain analysis, we demonstrate the utility of a staging model of schizophrenia. We show that for FE drug-naïve patients, changes are most evident in language regions such as Broca’s area, which may underlie the thought disorders central to schizophrenia symptoms. This is consistent with the hypothesis that schizophrenia is the price that Homo sapiens pays for language made by Crow. For the chronic stage, more widespread changes were found, most prominently in thalamo-cortical connections. These results are of importance for understanding the pathogenesis of schizophrenia, and for providing sensitive neurobiological markers crucial for early diagnosis and treatment.

Funding

L.T. is supported by National Nature Science Foundation of China Key Project (NO. 81130024). Q.W. is supported by National Nature Science Foundation of China Grant (NSFC 81271479). J.Z. is supported by National Science Foundation of China (NSFC 61104143 and 61573107), and special Funds for Major State Basic Research Projects of China (2015CB856003). J.F is a Royal Society Wolfson Research Merit Award holder. J.F. is also partially supported by the National High Technology Research and Development Program of China (No. 2015AA020507) and the key project of Shanghai Science & Technology Innovation Plan (No. 15JC1400101). The research was partially supported by the National Centre for Mathematics and Interdisciplinary Sciences (NCMIS) of the Chinese Academy of Sciences and Key Program of National Natural Science Foundation of China (No. 91230201). J.W. is supported by Shanghai Science and Technology Committee (14411961400). L.P. was partly supported by the Wellcome Trust (Research Training Fellowship) during the course of this work. Q.L. is supported by grants from the National Natural Sciences Foundation of China (No. 11101429, No.11471081). Z.L. was supported by the National Natural Science Foundation of China (81271485, 81471362). J.W. acknowledges support from the Shanghai Key Laboratory of Psychotic Disorders (13dz2260500). C.L. acknowledges support from the SHSMU-ION Research Center for Brain Disorders (2015NKX001).

Acknowledgment

The authors have declared that there are no conflicts of interest in relation to the subject of this study.

References

1.

Bullmore
E
Frangou
S
Murray
R
.
The dysplastic net hypothesis: an integration of developmental and dysconnectivity theories of schizophrenia
.
Schizophr Res
.
1997
;
28
:
143
156
.

2.

Pettersson-Yeo
W
Allen
P
Benetti
S
McGuire
P
Mechelli
A
.
Dysconnectivity in schizophrenia: where are we now?
Neurosci Biobehav Rev
.
2011
;
35
:
1110
1124
.

3.

Weinberger
DR
Egan
MF
Bertolino
A
et al. 
Prefrontal neurons and the genetics of schizophrenia
.
Biol Psychiatry
.
2001
;
50
:
825
844
.

4.

Potkin
S
Turner
J
Brown
G
et al. 
Working memory and DLPFC inefficiency in schizophrenia: the FBIRN study
.
Schizophr Bulletin
.
2009
;
35
:
19
31
.

5.

MacDonald
III
AW
Carter
CS
Kerns
JG
et al. 
Specificity of prefrontal dysfunction and context processing deficits to schizophrenia in never-medicated patients with first-episode psychosis
.
Am J Psychiatry
.
2005
;
162
:
475
484
.

6.

Snitz
BE
MacDonald
A
III
Cohen
JD
Cho
RY
Becker
T
Carter
CS
.
Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment
.
Am J Psychiatry
.
2005
;
162
:
2322
2329
.

7.

Baker
JT
Holmes
AJ
Masters
GA
et al. 
Disruption of cortical association networks in schizophrenia and psychotic bipolar disorder
.
JAMA Psychiatry
.
2014
;
71
:
109
118
.

8.

Barch
DM
Ceaser
A
.
Cognition in schizophrenia: core psychological and neural mechanisms
.
Trends Cogn Sci
.
2012
;
16
:
27
34
.

9.

Pol
HEH
Kahn
RS
.
What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia
.
Schizophr Bull
.
2008
;
34
:
354
366
.

10.

Cole
MW
Anticevic
A
Repovs
G
Barch
D
.
Variable global dysconnectivity and individual differences in schizophrenia
.
Biol Psychiat
.
2011
;
70
:
43
50
.

11.

Thermenos
HW
Whitfield-Gabrieli
S
Seidman
LJ
et al. 
Altered language network activity in young people at familial high-risk for schizophrenia
.
Schizophr Res
.
2013
;
151
:
229
237
.

12.

Benetti
S
Mechelli
A
Picchioni
M
Broome
M
Williams
S
McGuire
P
.
Functional integration between the posterior hippocampus and prefrontal cortex is impaired in both first episode schizophrenia and the at risk mental state
.
Brain
.
2009
;
132
:
2426
2436
.

13.

Kaufmann
T
Skatun
KC
Alnaes
D
et al.  .
Disintegration of sensorimotor brain networks in schizophrenia
.
Schizophrenia Bull
.
2015
;
41
:
1326
1335
.

14.

Crossley
NA
Mechelli
A
Fusar-Poli
P
et al. 
Superior temporal lobe dysfunction and frontotemporal dysconnectivity in subjects at risk of psychosis and in first-episode psychosis
.
Hum Brain Mapp
.
2009
;
30
:
4129
4137
.

15.

Carter
CS
MacDonald
AW
III
Ross
LL
Stenger
VA
.
Anterior cingulate cortex activity and impaired self-monitoring of performance in patients with schizophrenia: an event-related fMRI study
.
Am J Psychiatry
.
2001
;
158
:
1423
1428
.

16.

Meyer-Lindenberg
AS
Olsen
RK
Kohn
PD
et al. 
Regionally specific disturbance of dorsolateral prefrontal–hippocampal functional connectivity in schizophrenia
.
Arch Gen Psychiatry
.
2005
;
62
:
379
386
.

17.

Guller
Y
Ferrarelli
F
Shackman
AJ
et al. 
Probing thalamic integrity in schizophrenia using concurrent transcranial magnetic stimulation and functional magnetic resonance imaging
.
Arch Gen Psychiatry
.
2012
;
69
:
662
671
.

18.

Pinault
D
.
Dysfunctional thalamus-related networks in schizophrenia
.
Schizophr Bull
.
2011
;
37
:
238
243
.

19.

Cheng
W
Palaniyappan
L
Li
M
et al. 
Voxel-based, brain-wide association study of aberrant functional connectivity in schizophrenia implicates thalamocortical circuitry
.
NPJ Schizophr
.
2015
;
1
:
15016
.

20.

Anticevic
A
Cole
MW
Repovs
G
et al. 
Characterizing thalamo-cortical disturbances in schizophrenia and bipolar illness
.
Cereb Cortex
.
2014
;
24
:
3116
3130
.

21.

Woodward
ND
Heckers
S
.
Mapping thalamocortical functional connectivity in chronic and early stages of psychotic disorders
.
Biol Psychiatry
.
2016
;
79
:
1016
1025
.

22.

Welsh
RC
Chen
AC
Taylor
SF
.
Low-frequency BOLD fluctuations demonstrate altered thalamocortical connectivity in schizophrenia
.
Schizophr Bull
.
2010
;
36
:
713
722
.

23.

Woodward
ND
Karbasforoushan
H
Heckers
S
.
Thalamocortical dysconnectivity in schizophrenia
.
Am J Psychiatry
.
2012
;
169
:
1092
1099
.

24.

Marenco
S
Stein
JL
Savostyanova
AA
et al. 
Investigation of anatomical thalamo-cortical connectivity and FMRI activation in schizophrenia
.
Neuropsychopharmacol
.
2012
;
37
:
499
507
.

25.

Fusar-Poli
P
Allen
P
McGuire
P
.
Neuroimaging studies of the early stages of psychosis: a critical review
.
European Psychiatry
.
2008
;
23
:
237
244
.

26.

Wood
SJ
Yung
AR
McGorry
PD
Pantelis
C
.
Neuroimaging and treatment evidence for clinical staging in psychotic disorders: from the at-risk mental state to chronic schizophrenia
.
Biol Psychiatry
.
2011
;
70
:
619
625
.

27.

Lin
A
Reniers
RL
Wood
SJ
.
Clinical staging in severe mental disorder: evidence from neurocognition and neuroimaging
.
Brit J Psychiatry
.
2013
;
202
:
s11
s17
.

28.

McGorry
PD
.
Issues for DSM-V: clinical staging: a heuristic pathway to valid nosology and safer, more effective treatment in psychiatry
.
Am J Psychiatry
.
2007
;
164
:
859
860
.

29.

Benetti
S
Mechelli
A
Picchioni
M
Broome
M
Williams
S
McGuire
P
.
Functional integration between the posterior hippocampus and prefrontal cortex is impaired in both first episode schizophrenia and the at risk mental state
.
Brain
.
2009
;
132
:
2426
2436
.

30.

Allen
P
Luigjes
J
Howes
OD
et al. 
Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals
.
Schizophr Bull
.
2012
;
38
:
1268
1276
.

31.

Glahn
DC
Laird
AR
Ellison-Wright
I
et al. 
Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis
.
Biol Psychiatry
.
2008
;
64
:
774
781
.

32.

Petrides
M.
Neuroanatomy of Language Regions of the Human Brain
.
New York, NY
:
Academic Press
;
2014
.

33.

Tao
H
Guo
S
Ge
T
Kendrick
KM
Xue
Z
Liu
Z
Feng
J
.
Depression uncouples brain hate circuit
.
Mol Psychiatry
.
2013
;
18
:
101
111
.

34.

Cheng
W
Rolls
ET
Gu
H
Zhang
J
Feng
J
.
Autism: reduced connectivity between cortical areas involved in face expression, theory of mind, and the sense of self
.
Brain
2015
;
138
:
1382
1393
.

35.

Guo
S
Kendrick
KM
Yu
R
Wang
HL
Feng
J
.
Key functional circuitry altered in schizophrenia involves parietal regions associated with sense of self
.
Hum Brain Mapp
.
2014
;
35
:
123
139
.

36.

Mayer
AR
Ruhl
D
Merideth
F
et al. 
Functional imaging of the hemodynamic sensory gating response in schizophrenia
.
Human Brain Mapp
.
2013
;
34
:
2302
2312
.

37.

Guo
S
Kendrick
KM
Zhang
J
et al. 
Brain-wide functional inter-hemispheric disconnection is a potential biomarker for schizophrenia and distinguishes it from depression
.
Neuroimage Clin
.
2013
;
2
:
818
826
.

38.

Anticevic
A
Tang
Y
Cho
YT
et al. 
Amygdala connectivity differs among chronic, early course, and individuals at risk for developing schizophrenia
.
Schizophr Bull
.
2014
;
40
:
1105
1116
.

39.

First
M
Spitzer
R
Gibbon
M
Williams
J.
Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician Version (SCID-CV), 1997
.
Washington, DC
:
American Psychiatric Association Press
;
2007
.

40.

Kay
SR
Flszbein
A
Opfer
LA
.
The positive and negative syndrome scale (PANSS) for schizophrenia
.
Schizophr Bull
.
1987
;
13
:
261
.

41.

Tzourio-Mazoyer
N
Landeau
B
Papathanassiou
D
et al. 
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain
.
Neuroimage
.
2002
;
15
:
273
289
.

42.

Power
JD
Barnes
KA
Snyder
AZ
Schlaggar
BL
Petersen
SE
.
Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion
.
Neuroimage
.
2012
;
59
:
2142
2154
.

43.

Liptak
T
.
On the combination of independent tests
.
Magyar Tud Akad Mat Kutato Int Kozl
.
1958
;
3
:
171
197
.

44.

Zhou
Y
Liang
M
Jiang
T
et al. 
Functional dysconnectivity of the dorsolateral prefrontal cortex in first-episode schizophrenia using resting-state fMRI
.
Neurosci Lett
.
2007
;
417
:
297
302
.

45.

Ren
W
Lui
S
Deng
W
et al. 
Anatomical and functional brain abnormalities in drug-maive first-episode schizophrenia
.
Am J Psychiatry
.
2013
;
170
:
1308
1316
.

46.

Greenlee
JD
Oya
H
Kawasaki
H
et al. 
Functional connections within the human inferior frontal gyrus
.
J Comp Neurol
.
2007
;
503
:
550
559
.

47.

Friederici
AD
.
The cortical language circuit: from auditory perception to sentence comprehension
.
Trends Cogn Sci
.
2012
;
16
:
262
268
.

48.

Rolls
ET.
Emotion and Decision-Making Explained
.
Oxford, UK
:
Oxford University Press
;
2014
.

49.

Berlim
MT
Mattevi
BS
Belmonte-de-Abreu
P
Crow
TJ
.
The etiology of schizophrenia and the origin of language: overview of a theory
.
Compr Psychiatry
.
2003
;
44
:
7
14
.

50.

Cronenwett
WJ
Csernansky
J
.
Thalamic pathology in schizophrenia
.
Behavioral Neurobiology of Schizophrenia and Its Treatment
.
New York, NY
:
Springer
;
2010
:
509
528
.

51.

Anticevic
A
Haut
K
Murray
JD
et al. 
Association of thalamic dysconnectivity and conversion to psychosis in youth and young adults at elevated clinical risk
.
JAMA Psychiatry
.
2015
;
72
:
882
891
.

52.

Craddock
RC
James
GA
Holtzheimer
PE
Hu
XPP
Mayberg
HS
.
A whole brain fMRI atlas generated via spatially constrained spectral clustering
.
Hum Brain Mapp
.
2012
;
33
:
1914
1928
.

Author notes

20These authors contributed equally to the work.

*Correspondence should be addressed to Prof. Jie Zhang, Institute of Science and Technology for Brain Inspired Intelligence, Fudan University, 220 Handan Rd., Yangpu District, Shanghai 200433, PR China; e-mail: jzhang080@gmail.com. Correspondence can also be addressed to Prof. Fei Wang, Psychiatry department, The First Affiliated Hospital, China Medical University, Shenyang, Liaoning, PR China; e-mail: fei.wang@yale.edu

Supplementary data